Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in TERN — Terns Pharmaceuticals, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in TERN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
521,571
+6765.5% QoQ
Ownership
0.451%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TERN Over Time

Shares Held

Position Value (USD)

Derivatives in TERN

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
1,016,400
PutValue
$0
PutShares
597,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,650,012,247 across 349 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in TERN

Export CSV
34 filing rows on record
Report Date Value (USD) Shares
2026-03-31 597,300
2026-03-31 521,571
2026-03-31 1,016,400
2025-12-31 66,200
2025-12-31 469,600
2025-12-31 7,597
2025-09-30 13,100
2025-09-30 170,300
2025-06-30 12,400
2025-06-30 87,623
2025-03-31 125,700
2025-03-31 91,174
2024-12-31 35,889
2024-12-31 249,900
2024-12-31 43,400
2024-09-30 249,100
2024-09-30 170,100
2024-09-30 45,878
2024-06-30 35,830
2024-06-30 80,700
2024-06-30 258,900
2024-03-31 29,100
2024-03-31 101,400
2024-03-31 19,743
2023-12-31 45,100
2023-12-31 22,700
2023-12-31 62,444
2023-09-30 39,106
2023-09-30 31,700
2023-06-30 15,300
2023-06-30 92,000
2023-06-30 164,851
2023-03-31 328,028
2022-12-31 38,102